Merck & Co.'s Lipfendra approved in US as first oral PCSK9 inhibitor - FirstWord PHARMA
Merck & Co.'s Lipfendra approved in US as first oral PCSK9 inhibitor FirstWord PHARMA
Merck & Co Company News
Merck & Co Inc Stock (MRK) Moved Up by 3.24% on Jul 16: Drivers Behind the Movement - TradingKey
Merck & Co Inc Stock (MRK) Moved Up by 3.24% on Jul 16: Drivers Behind the Movement TradingKey
Merck stock trades near record territory as oncology and vaccines drive revenue growth - Ad Hoc News
Merck stock trades near record territory as oncology and vaccines drive revenue growth Ad Hoc News
Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne - Reuters
Germany's Merck boosts life sciences business with $11 billion bet on Bio-Techne Reuters
Our Q4 and full-year 2025 financial results - Merck.com
Our Q4 and full-year 2025 financial results Merck.com
Merck to split cancer, specialty drug businesses in leadership shakeup - BioPharma Dive
Merck to split cancer, specialty drug businesses in leadership shakeup BioPharma Dive
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 - Business Wire
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4 Business Wire
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline - CNBC
Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline CNBC
Girding against Keytruda cliff, Merck splits oncology into standalone business unit - Fierce Pharma
Girding against Keytruda cliff, Merck splits oncology into standalone business unit Fierce Pharma
Merck & Co (MRK) BofA Securities 2025 Healthcare Conference Summary - Quartr
Merck & Co (MRK) BofA Securities 2025 Healthcare Conference Summary Quartr
‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation - International Consortium of Investigative Journalists - ICIJ
‘Unacceptable’: Lawmakers react to revelations from ICIJ’s Cancer Calculus investigation International Consortium of Investigative Journalists - ICIJ
Merck & Co. (MRK): Our Calculation of Intrinsic Value - The Acquirer's Multiple
Merck & Co. (MRK): Our Calculation of Intrinsic Value The Acquirer's Multiple
Merck & Co Inc Stock (MRK) Moved Up by 3.05% on Jul 15: Key Drivers Unveiled - TradingKey
Merck & Co Inc Stock (MRK) Moved Up by 3.05% on Jul 15: Key Drivers Unveiled TradingKey
Merck stock edges higher as Keytruda drives double digit growth - Ad Hoc News
Merck stock edges higher as Keytruda drives double digit growth Ad Hoc News
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) - Merck.com
FDA Approves Merck’s Once-Daily IDVYNSO™ (doravirine/islatravir) Merck.com
Merck & Co.'s tulisokibart scores pivotal TL1A victory in ulcerative colitis - FirstWord PHARMA
Merck & Co.'s tulisokibart scores pivotal TL1A victory in ulcerative colitis FirstWord PHARMA
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide - International Consortium of Investigative Journalists - ICIJ
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide International Consortium of Investigative Journalists - ICIJ
The new manufacturing facilities powering our US growth - Merck.com
The new manufacturing facilities powering our US growth Merck.com
Merck & Co Inc Stock (MRK) Moved Up by 4.04% on Jun 25: A Full Analysis - TradingKey
Merck & Co Inc Stock (MRK) Moved Up by 4.04% on Jun 25: A Full Analysis TradingKey
Merck stock stays centered on earnings and Keytruda - Ad Hoc News
Merck stock stays centered on earnings and Keytruda Ad Hoc News
Merck & Co. (MRK) Announces Quarterly Dividend - Yahoo Finance
Merck & Co. (MRK) Announces Quarterly Dividend Yahoo Finance
Merck exec says company is discussing use of COVID antiviral drug in Ebola response - Reuters
Merck exec says company is discussing use of COVID antiviral drug in Ebola response Reuters
Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances - Fierce Pharma
Merck shrinks headcount by 88 in New Jersey as $3B cost-cutting scheme advances Fierce Pharma
Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug - BioPharma Dive
Merck to buy Terns in $6.7B bet on a ‘differentiated’ leukemia drug BioPharma Dive
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine - Mayo Clinic News Network
Merck and Mayo Clinic Announce New Research and Development Collaboration to Support AI-Enabled Drug Discovery and Precision Medicine Mayo Clinic News Network
Merck—ad spending, facts and profile - Ad Age
Merck—ad spending, facts and profile Ad Age
Merck & Co Inc Stock (MRK) Opened Up by 4.50% on May 22: Facts Behind the Movement - TradingKey
Merck & Co Inc Stock (MRK) Opened Up by 4.50% on May 22: Facts Behind the Movement TradingKey
Top Research Reports for Merck, Southern Company & Lumentum - Yahoo Finance
Top Research Reports for Merck, Southern Company & Lumentum Yahoo Finance
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B - Fierce Pharma
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B Fierce Pharma
Terns rebuffed a higher bid before selling to Merck - BioPharma Dive
Terns rebuffed a higher bid before selling to Merck BioPharma Dive
Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners? - Yahoo Finance
Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners? Yahoo Finance
With Gardasil demand shortfall in China, Merck and Zhifei adjust their partnership - Fierce Pharma
With Gardasil demand shortfall in China, Merck and Zhifei adjust their partnership Fierce Pharma
Merck & Co Inc Stock (MRK) Closed Up by 3.16% on Jul 2: What Signal Does It Send? - TradingKey
Merck & Co Inc Stock (MRK) Closed Up by 3.16% on Jul 2: What Signal Does It Send? TradingKey
Strong Results Lifted Merck & Co (MRK) in Q4 - Yahoo Finance
Strong Results Lifted Merck & Co (MRK) in Q4 Yahoo Finance
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? - Yahoo Finance
Is Merck & Co., Inc. (MRK) A Good Stock To Buy Now? Yahoo Finance
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss - Yahoo Finance
This is What Merck & Co. (MRK) is Doing to Mitigate Against KEYTRUDA Exclusivity Loss Yahoo Finance
Merck & Co. stock holds steady as oncology pipeline and Keytruda franchise underpin long-term growth - Ad Hoc News
Merck & Co. stock holds steady as oncology pipeline and Keytruda franchise underpin long-term growth Ad Hoc News
Merck strikes deal with antibody discovery startup - BioPharma Dive
Merck strikes deal with antibody discovery startup BioPharma Dive
Merck & Co.'s first pivotal study of sac-TMT comes up trumps - FirstWord PHARMA
Merck & Co.'s first pivotal study of sac-TMT comes up trumps FirstWord PHARMA
What Makes Merck & Co. (MRK) an Investment Bet? - Yahoo Finance
What Makes Merck & Co. (MRK) an Investment Bet? Yahoo Finance